Evidence map›Paper›PMID 39229561›Full record

ArticleAnnals of gastroenterological surgery2024

Impact of SARS-CoV-2 infection on short-term postoperative outcomes after gastroenterological cancer surgery using data from a nationwide database in Japan.

Masashi Takeuchi, Taizo Hibi, Ryo Seishima, Yusuke Takemura, Hiromichi Maeda, Genta Toshima, Noriyuki Ishida, Naoki Miyazaki, Akinobu Taketomi, Yoshihiro Kakeji and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of gastroenterological surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Masashi TakeuchiDepartment of Surgery Keio University School of Medicine Shinjuku-ku Tokyo Japan.ORCID https://orcid.org/0000-0003-3797-432X
Taizo HibiDepartment of Pediatric Surgery and Transplantation Kumamoto University Graduate School of Medical Sciences Kumamoto Japan.ORCID https://orcid.org/0000-0002-6867-228X
Ryo SeishimaDepartment of Surgery Keio University School of Medicine Shinjuku-ku Tokyo Japan.
Yusuke TakemuraDepartment of Surgery Keio University School of Medicine Shinjuku-ku Tokyo Japan.ORCID https://orcid.org/0000-0003-3791-9902
Hiromichi MaedaDepartment of Surgery Kochi Medical School Kochi Japan.ORCID https://orcid.org/0000-0001-7694-8082
Genta ToshimaBiostatistics Unit, Clinical and Translational Research Center Keio University Hospital Shinjuku-ku Tokyo Japan.
Noriyuki IshidaBiostatistics Unit, Clinical and Translational Research Center Keio University Hospital Shinjuku-ku Tokyo Japan.
Naoki MiyazakiBiostatistics Unit, Clinical and Translational Research Center Keio University Hospital Shinjuku-ku Tokyo Japan.
Akinobu TaketomiDepartment of Gastroenterological Surgery I Hokkaido University Hospital Sapporo Hokkaido Japan.
Yoshihiro KakejiDatabase Committee, The Japanese Society of Gastroenterological Surgery Minato-ku Tokyo Japan.ORCID https://orcid.org/0000-0002-2727-0241
Yasuyuki SetoDepartment of Gastrointestinal Surgery, Graduate School of Medicine University of Tokyo Bunkyo-ku Tokyo Japan.ORCID https://orcid.org/0000-0002-6953-8752
Hideki UenoDatabase Committee, The Japanese Society of Gastroenterological Surgery Minato-ku Tokyo Japan.ORCID https://orcid.org/0000-0002-8600-1199
Masaki MoriTokai University Hiratsuka Kanagawa Japan.
Ken ShirabeDepartment of General Surgical Science Gunma University Graduate School of Medicine Maebashi Gunma Japan.
Yuko KitagawaDepartment of Surgery Keio University School of Medicine Shinjuku-ku Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Due to the coronavirus disease 2019 (COVID-19) pandemic, cancer screening, diagnosis, and treatment have changed. This study aimed to investigate the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection prior to gastroenterological cancer surgeries on postoperative complications using data from a nationwide database in Japan. Methods: Data on patients who underwent surgery for cancer including esophageal, gastric, colon, rectal, liver, and pancreatic cancer between July 1, 2019, and September 300, 2022, from real-world sources in Japan were analyzed. The association between preoperative SARS-CoV-2 infection and short-term postoperative outcomes was evaluated. A similar analysis stratified according to the interval from SARS-CoV-2 infection to surgery (<4 vs. >4 weeks) was conducted. Results: In total, 60 604 patients were analyzed, and 227 (0.4%) patients were diagnosed with SARS-CoV-2 infection preoperatively. The median interval from SARS-CoV-2 infection to surgery was 25 days. Patients diagnosed with SARS-CoV-2 infection preoperatively had a significantly higher incidence of pneumonia (odds ratio: 2.05; 95% confidence interval: 1.05-3.74; Conclusions: Patients with a history of SARS-CoV-2 infection had a significantly higher incidence of pneumonia. This finding can be particularly valuable for countries that have implemented strict regulations in response to the COVID-19 pandemic and have lower SARS-CoV-2 infection-related mortality rates.

Indexed as

gastroenterological cancer surgerynationwide databaseSARS‐CoV‐2 infection

Identifiers

PMID39229561
PMCPMC11368505

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.